About Us

 Dr. Li is the President and founder of Oncotargeting.  He has over 15 years of experience leading a successful research lab at UVA as well as being the Cancer Center Program Leader and founded the new RNA center at UVA.  His discovery of advillin as an oncogene in glioblastoma has led to the first in class inhibitors of advillin as novel cancer therapeutics.

 Dr. Cornelison is the Chief Executive Officer of Oncotargeting LLC. He has over 25 years of experience in molecular biology and oncology spanning NCI, NHGRI, Advanced Bioscience Laboratories, Johns Hopkins University, University of Virginia and UVA startups.

Dr. Xie is the co-founder of Oncotargeting and the staff scientist leading the research into advillin's role in neoplasia.  He has over 20 years of experience in the lab and has over 40 publications.